OEA Supplementation Boosts Akkermansia & Improves Gut Health in Obesity Study

The gut microbiome—the complex community of microorganisms living in our digestive tracts—continues to reveal itself as a central player in overall health. Recent research published in Gut Microbes Reports suggests that supplementation with oleoylethanolamide (OEA), a naturally occurring fatty acid amide, may positively influence the gut microbiome, specifically by boosting levels of Akkermansia muciniphila and improving gut barrier function. This is particularly relevant as disruptions in gut health are increasingly linked to a range of conditions, from obesity and metabolic syndrome to inflammatory diseases.

OEA, Akkermansia and a Stronger Gut Barrier

The randomized, double-blind, placebo-controlled trial involved 44 adults with obesity. Participants received either 300 mg per day of Trpti, a bioavailable form of OEA developed by Saanroo, or a placebo for 12 weeks. Researchers found that OEA supplementation was associated with a significant enrichment of Akkermansia muciniphila, a bacterium increasingly recognized for its health-promoting properties. They too observed an increase in Faecalibacterium prausnitzii, another beneficial gut microbe known for producing butyrate, a short-chain fatty acid that nourishes the cells lining the colon.

Akkermansia muciniphila is of particular interest. This bacterium resides in the mucus layer of the gut and plays a role in maintaining the integrity of the intestinal barrier. According to research published in the Journal of Clinical Investigation, its abundance is often inversely correlated with body mass index (BMI), type 1 diabetes, and inflammatory bowel disease. A healthy intestinal barrier prevents the leakage of harmful substances into the bloodstream, reducing systemic inflammation. The study also noted increases in occludin, a protein crucial for tight junctions between intestinal cells, further supporting the idea of improved gut barrier function.

How OEA Works: Beyond the Gut

OEA is produced naturally in the small intestine in response to dietary fat. It interacts with the endocannabinoid system—a complex network involved in regulating various physiological processes—without producing psychoactive effects. It’s thought to influence satiety signaling, lipid metabolism, and inflammation. The recent study suggests OEA may also act as a “microbiome modulator,” selectively encouraging the growth of beneficial bacteria. Researchers observed changes in interleukin levels, indicating improved gut barrier dynamics and reduced inflammation. Obesity is often characterized by low-grade inflammation and a compromised gut barrier, so these findings are particularly noteworthy.

Study Details and Nuances

The study, conducted by scientists at Central Queensland University and the University of Queensland in Australia, initially enrolled 57 obese adults aged 23 to 64. Data from the 44 participants who completed the 12-week trial revealed a 0.53% increase in A. Muciniphila and a 1.31% increase in F. Prausnitzii in the OEA group compared to the placebo group. Although these increases may seem small, researchers emphasize that even modest shifts in gut microbial composition can have significant health implications.

Importantly, the study also found that overall microbial diversity remained stable. This is a crucial observation, as drastic alterations in the microbiome can sometimes be detrimental. The researchers noted that the observed effects were specific to OEA supplementation, as the placebo group showed no significant changes in microbial composition or immune markers. Functional metagenomics analysis indicated enhanced antioxidant, redox, and amino acid metabolism pathways, suggesting targeted improvements in gut homeostasis.

From Gencor to Saanroo: The Development of Trpti

The OEA used in the study, branded as Trpti, was originally developed by Gencor. In October 2025, Gencor spun out its nutraceutical division as Saanroo, as reported by NutraIngredients, to focus specifically on botanical ingredients for healthy aging and metabolic wellness. Ramasamy Venkatesh, managing director at Gencor Pacific, highlighted that Trpti supplementation demonstrated a more favorable gut microbiome signature and microbial functional capacity, alongside trends toward modest metabolic benefits, while maintaining safety and tolerability.

What Which means for Metabolic Health

The findings suggest that OEA supplementation could be a promising strategy for supporting metabolic health and improving gut function, particularly in individuals with obesity. The enrichment of Akkermansia muciniphila and Faecalibacterium prausnitzii, coupled with improvements in gut barrier integrity and reduced inflammation, points to a potential mechanism for mitigating metabolic dysfunction. However, it’s crucial to remember that this is a single study, and further research is needed to confirm these findings and explore potential dose-response relationships and individual variability.

Looking Ahead: Further Research and Clinical Applications

The researchers call for additional studies to fully elucidate the mechanisms of action underlying OEA’s effects on the gut microbiome. Future research should also investigate whether OEA supplementation can provide benefits for other populations beyond those with obesity, such as individuals with inflammatory bowel disease or other gut-related disorders. Exploring potential synergistic effects with other dietary interventions or probiotic supplements could also be a fruitful area of investigation. The study’s authors also suggest that larger, longer-term trials are needed to assess the clinical significance of these findings and determine the optimal dosage and duration of OEA supplementation. Saanroo provides information on Trpti and its potential benefits, but it’s important to consult with a qualified healthcare professional before starting any modern supplement regimen.